We are live on ! Find out more
GILD icon

Gilead Sciences

1,491 hedge funds and large institutions have $66.2B invested in Gilead Sciences in 2019 Q1 according to their latest regulatory filings, with 119 funds opening new positions, 600 increasing their positions, 607 reducing their positions, and 108 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more first-time investments, than exits

New positions opened: 119 | Existing positions closed: 108

4% more capital invested

Capital invested by funds: $63.4B → $66.2B (+$2.81B)

0.8% more ownership

Funds ownership: 79.26%80.06% (+0.8%)

0% less funds holding

Funds holding: 1,4961,491 (-5)

1% less repeat investments, than reductions

Existing positions increased: 600 | Existing positions reduced: 607

12% less funds holding in top 10

Funds holding in top 10: 5044 (-6)

23% less call options, than puts

Call options by funds: $835M | Put options by funds: $1.09B

Holders
1,491
Holders Change
-5
Holders Change %
-0.33%
% of All Funds
32.27%
Holding in Top 10
44
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-12%
% of All Funds
0.95%
New
119
Increased
600
Reduced
607
Closed
108
Calls
$835M
Puts
$1.09B
Net Calls
-$254M
Net Calls Change
+$14.1M
Name Holding Trade Value Shares
Change
Change in
Stake
HI
1501
Honeywell International
North Carolina
-$13M -207,500 Closed
RPAM
1502
Rhenman & Partners Asset Management
Sweden
-$11.8M -188,200 Closed
CIM
1503
Contrarius Investment Management
Jersey
-$8.91M -142,465 Closed
Marshall Wace
1504
Marshall Wace
United Kingdom
-$7.7M -123,013 Closed
KC
1505
Kepos Capital
New York
-$6.57M -105,041 Closed
LCM
1506
Laurion Capital Management
New York
-$6.35M -101,572 Closed
MAM
1507
Mastrapasqua Asset Management
Tennessee
-$5.38M -85,982 Closed
ACPU
1508
Arrowgrass Capital Partners (US)
Delaware
-$4.95M -79,125 Closed
ACM
1509
Advent Capital Management
New York
-$4.88M -78,000 Closed
QAM
1510
Quantres Asset Management
Cayman Islands
-$4.75M -75,900 Closed
YMRC
1511
Yorktown Management & Research Company
Virginia
-$4.38M -70,000 Closed
OSAM
1512
O'Shaughnessy Asset Management
Connecticut
-$3.29M -52,650 Closed
APFBOT
1513
Amica Pension Fund Board of Trustees
Rhode Island
-$3.13M -49,986 Closed
DC
1514
Diametric Capital
Massachusetts
-$3.03M -48,511 Closed
1832 Asset Management
1515
1832 Asset Management
Ontario, Canada
-$2.62M -39,630 Closed
TAA
1516
TB Alternative Assets
Cayman Islands
-$2.3M -36,700 Closed
CI
1517
Capital International
California
-$2.28M -36,484 Closed
AC
1518
Argentiere Capital
Switzerland
-$2.19M -35,000 Closed
CCA
1519
Cobblestone Capital Advisors
New York
-$1.99M -31,786 Closed
KHLMVGHM
1520
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet
Israel
-$1.78M -28,434 Closed
MS
1521
Marshall & Sullivan
Washington
-$1.64M -26,179 Closed
CC
1522
Colrain Capital
Massachusetts
-$1.29M -20,680 Closed
APTFM
1523
AGUR Provident & Training Funds Management
Israel
-$1.43M -19,509 Closed
3C
1524
361 Capital
Colorado
-$1.15M -18,331 Closed
BA
1525
Bristol Advisors
Pennsylvania
-$1.13M -18,000 Closed

GILD Hedge Fund Activity: Q1 2019 in Review

1,491 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q1 2019, worth a combined $66.2B — up 4.4% from $63.4B a quarter earlier.

Buyers outnumbered sellers: 119 funds opened new GILD positions and 108 closed out — a net gain of 11 holders — while 600 added to existing stakes and 607 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $375M. The largest seller was Temasek Holdings, exiting entirely with an estimated $696M sold.

  • 1,491 institutional investors held Gilead Sciences (GILD) as of Q1 2019, down from 1,496 in Q4 2018.
  • Funds reported $66.2B of Gilead Sciences stock for Q1 2019, up 4.4% quarter-over-quarter.
  • 119 funds opened new Gilead Sciences positions in Q1 2019 and 108 closed out, a net change of +11 holders.
  • The largest Gilead Sciences buyer in Q1 2019 was Capital Research Global Investors, an estimated $375M added.
  • The largest Gilead Sciences seller in Q1 2019 was Temasek Holdings, an estimated $696M sold.

Based on aggregated 13F filings for Q1 2019.